Overview

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

Status:
Terminated
Trial end date:
2015-05-29
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of etanercept in patients with plaque psoriasis who have lost a satisfactory response to adalimumab.
Phase:
Phase 4
Details
Lead Sponsor:
Amgen
Treatments:
Adalimumab
Etanercept